Literature DB >> 16520918

Increased clonogenic potential of circulating endothelial progenitor cells in patients with type 1 diabetes and proliferative retinopathy.

V Asnaghi, R Lattanzio, G Mazzolari, M R Pastore, A Ramoni, A Maestroni, D Ruggieri, L Luzi, R Brancato, G Zerbini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16520918     DOI： 10.1007/s00125-006-0180-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  13 in total

1.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Authors:  Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

2.  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).

Authors:  Birgit Assmus; Volker Schächinger; Claudius Teupe; Martina Britten; Ralf Lehmann; Natascha Döbert; Frank Grünwald; Alexandra Aicher; Carmen Urbich; Hans Martin; Dieter Hoelzer; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

3.  Contribution of bone marrow-derived endothelial cells to human tumor vasculature.

Authors:  Brock A Peters; Luis A Diaz; Kornelia Polyak; Leslie Meszler; Kathy Romans; Eva C Guinan; Joseph H Antin; David Myerson; Stanley R Hamilton; Bert Vogelstein; Kenneth W Kinzler; Christoph Lengauer
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

4.  Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.

Authors:  I G Lee; S L Chae; J C Kim
Journal:  Eye (Lond)       Date:  2006-05       Impact factor: 3.775

5.  Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.

Authors:  Oren M Tepper; Robert D Galiano; Jennifer M Capla; Christoph Kalka; Paul J Gagne; Glen R Jacobowitz; Jamie P Levine; Geoffrey C Gurtner
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

6.  SDF-1 is both necessary and sufficient to promote proliferative retinopathy.

Authors:  Jason M Butler; Steven M Guthrie; Mehmet Koc; Aqeela Afzal; Sergio Caballero; H Logan Brooks; Robert N Mames; Mark S Segal; Maria B Grant; Edward W Scott
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

7.  Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization.

Authors:  Maria B Grant; W Stratford May; Sergio Caballero; Gary A J Brown; Steven M Guthrie; Robert N Mames; Barry J Byrne; Timothy Vaught; Polyxenie E Spoerri; Ammon B Peck; Edward W Scott
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

8.  Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation.

Authors:  Koji Yamamoto; Takahisa Kondo; Satoshi Suzuki; Hideo Izawa; Masayoshi Kobayashi; Nobuhiko Emi; Kimihiro Komori; Tomoki Naoe; Junki Takamatsu; Toyoaki Murohara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-14       Impact factor: 8.311

9.  Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis.

Authors:  Atsushi Otani; Karen Kinder; Karla Ewalt; Francella J Otero; Paul Schimmel; Martin Friedlander
Journal:  Nat Med       Date:  2002-07-29       Impact factor: 53.440

10.  Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

Authors:  Cindy J M Loomans; Eelco J P de Koning; Frank J T Staal; Maarten B Rookmaaker; Caroline Verseyden; Hetty C de Boer; Marianne C Verhaar; Branko Braam; Ton J Rabelink; Anton-Jan van Zonneveld
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461
View more
  7 in total

Review 1.  A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications.

Authors:  G P Fadini
Journal:  Diabetologia       Date:  2013-10-31       Impact factor: 10.122

Review 2.  Endothelial dysfunction in diabetes: the role of reparatory mechanisms.

Authors:  Angelo Avogaro; Mattia Albiero; Lisa Menegazzo; Saula de Kreutzenberg; Gian Paolo Fadini
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

3.  Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial.

Authors:  Benedetta Maria Bonora; Mattia Albiero; Mario Luca Morieri; Roberta Cappellari; Francesco Ivan Amendolagine; Marta Mazzucato; Alberto Zambon; Elisabetta Iori; Angelo Avogaro; Gian Paolo Fadini
Journal:  Diabetologia       Date:  2021-08-09       Impact factor: 10.122

4.  Role of FAM18B in diabetic retinopathy.

Authors:  Ai Ling Wang; Vidhya R Rao; Judy J Chen; Yves A Lussier; Jalees Rehman; Yong Huang; Rama D Jager; Michael A Grassi
Journal:  Mol Vis       Date:  2014-08-04       Impact factor: 2.367

Review 5.  Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease.

Authors:  Caterina Oriana Aragona; Egidio Imbalzano; Federica Mamone; Valentina Cairo; Alberto Lo Gullo; Angela D'Ascola; Maria Adriana Sardo; Michele Scuruchi; Giorgio Basile; Antonino Saitta; Giuseppe Mandraffino
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

Review 6.  Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.

Authors:  Olga Simó-Servat; Rafael Simó; Cristina Hernández
Journal:  J Diabetes Res       Date:  2016-06-08       Impact factor: 4.011

7.  Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness.

Authors:  Maria E Marketou; Athanasia Kalyva; Fragiskos I Parthenakis; Charalampos Pontikoglou; Spyros Maragkoudakis; Joanna E Kontaraki; Gregory Chlouverakis; Evangelos A Zacharis; Alexandros Patrianakos; Helen A Papadaki; Panos E Vardas
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-19       Impact factor: 3.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.